{{Rsnum
|rsid=4857855
|Chromosome=3
|position=128541707
|Orientation=plus
|GMAF=0.2126
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.9 | 27.4 | 2.7
| HCB | 47.4 | 44.5 | 8.0
| JPT | 55.8 | 36.3 | 8.0
| YRI | 80.3 | 18.4 | 1.4
| ASW | 73.7 | 26.3 | 0.0
| CHB | 47.4 | 44.5 | 8.0
| CHD | 42.2 | 45.9 | 11.9
| GIH | 61.4 | 35.6 | 3.0
| LWK | 81.8 | 18.2 | 0.0
| MEX | 64.9 | 31.6 | 3.5
| MKK | 91.0 | 9.0 | 0.0
| TSI | 63.7 | 33.3 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19198610
|Trait=Plasma eosinophil count
|Title=Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction
|RiskAllele=T
|Pval=9E-17
|OR=9.40
|ORtxt=[7.2-11.6] % standard unit increase
}}

{{PharmGKB
|RSID=rs4857855
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19198610; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. (Initial Sample Size: 9,392 individuals; Replication Sample Size: 12,118 individuals); (Region: 3q21.3; Reported Gene(s): GATA2; Risk Allele: rs4857855-T); (p-value= 0.00000000000000009).This variant is associated with Plasma eosinophil count.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164739963
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4857855
|overall_frequency_n=21
|overall_frequency_d=128
|overall_frequency=0.164062
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=17
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}